Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-Function Correlation With Optical Coherence Tomography-Derived Macular Thickness and Macular Microperimetry in Children, Adolescents, and Young Adults With Sickle Cell Disease.

Journal of vitreoretinal diseases·2026
Same author

Reference map of multimodal vision deficits in intermediate age-related macular degeneration: contrast sensitivity and low-contrast visual acuity.

The British journal of ophthalmology·2026
Same author

Acute Macular Neuroretinopathy and Peripheral Retinal Abnormalities in a Patient With Adams-Oliver Syndrome.

Journal of vitreoretinal diseases·2026
Same author

Rates, Timing, and Predictors of Retreatment Across Risk-Cohorts in Retinopathy of Prematurity: Intravitreal Bevacizumab Injection vs Laser.

American journal of ophthalmology·2026
Same author

Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation.

American journal of ophthalmology·2026
Same author

Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials.

Ophthalmology and therapy·2026

Related Experiment Video

Updated: Apr 25, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.1K

Dropless Vitreoretinal Surgery: A Review and Pooled Analysis.

Celine Chaaya, Srujay Pandiri, Sandra Hoyek

    Ophthalmic Surgery, Lasers & Imaging Retina
    |March 14, 2025
    PubMed
    Summary

    Dropless vitreoretinal surgery shows comparable outcomes to traditional methods, with no increased risk of infection or intraocular pressure. Further high-quality trials are needed to confirm these findings.

    More Related Videos

    Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
    11:20

    Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

    Published on: June 14, 2021

    3.7K
    Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
    04:16

    Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

    Published on: March 7, 2025

    215

    Related Experiment Videos

    Last Updated: Apr 25, 2026

    Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
    10:24

    Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

    Published on: February 12, 2018

    10.1K
    Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
    11:20

    Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

    Published on: June 14, 2021

    3.7K
    Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
    04:16

    Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

    Published on: March 7, 2025

    215

    Area of Science:

    • Ophthalmology
    • Surgical Innovation

    Background:

    • Traditional vitreoretinal surgery often requires post-operative antibiotic and steroid eye drops.
    • Concerns exist regarding patient compliance and potential complications associated with topical medications.

    Purpose of the Study:

    • To review the existing literature on dropless vitreoretinal surgery protocols and outcomes.
    • To assess the safety and efficacy of eliminating post-operative topical medications.

    Main Methods:

    • A comprehensive literature search was performed on PubMed (2004-2024).
    • Included studies were randomized controlled trials (RCTs) and observational studies.
    • Data extracted included protocols, patient characteristics, outcomes, and adverse events.

    Main Results:

    • Seven studies met the inclusion criteria, utilizing various antimicrobial and anti-inflammatory prophylaxis methods.
    • No increased rates of endophthalmitis or post-operative intraocular pressure were observed.
    • Moderate certainty suggests non-inferiority compared to conventional approaches.

    Conclusions:

    • Dropless vitreoretinal surgery protocols appear safe and effective, with outcomes comparable to traditional methods.
    • Higher quality evidence and prospective RCTs are warranted to strengthen conclusions.